Evidence map›Paper›PMID 35322293›Full record

SynthesisEuropean archives of psychiatry and clinical neuroscience2022

Emerging findings of glutamate-glutamine imbalance in the medial prefrontal cortex in attention deficit/hyperactivity disorder: systematic review and meta-analysis of spectroscopy studies.

Marcos Vinícius Vidor, Alana Castro Panzenhagen, Alexandre Ribeiro Martins, Renata Basso Cupertino, Cibele Edom Bandeira, Felipe Almeida Picon, Bruna Santos da Silva, Eduardo Schneider Vitola, Luis Augusto Rohde, Diego Luiz Rovaris and 2 more

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in European archives of psychiatry and clinical neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Reinventing amlodipine.The Journal of pharmacology and experimental therapeutics · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. New findings on attention/hyperactivity disorder: what is (not) known?European archives of psychiatry and clinical neuroscience · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Marcos Vinícius Vidor *Programa de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Alana Castro Panzenhagen *Programa de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Alexandre Ribeiro MartinsSerdil-Clínica de Radiologia e Diagnóstico de Imagem, Porto Alegre, RS, Brazil.
Renata Basso CupertinoPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Cibele Edom BandeiraPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Felipe Almeida PiconPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Bruna Santos da SilvaPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Eduardo Schneider VitolaPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Luis Augusto RohdePrograma de Pós-Graduação em Psiquiatria e Ciências do Comportamento, Universidade Federal do Rio Grande do Sul (UFRGS), R. Ramiro Barcelos, 2400, 2º andar, Porto Alegre, RS, 90035-003, Brazil.
Diego Luiz RovarisPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Claiton Henrique Dotto BauPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil.
Eugênio Horácio GrevetPrograma de Transtornos de Déficit de Atenção/Hiperatividade em Adultos (ProDAH-A), Centro de Pesquisa Clínica (CPC), Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil. eugenio.grevet@ufrgs.br.ORCID http://orcid.org/0000-0002-6898-7126
Universidade Federal do Rio Grande do Sul · BRHospital de Clínicas de Porto Alegre · BRCentrus Diagnósticos por Imagem · BRNational Council for Scientific and Technological Development · BRUniversidade de São Paulo · BRUniversity of Vermont · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the main challenges in investigating the neurobiology of ADHD is our limited capacity to study its neurochemistry in vivo. Magnetic resonance spectroscopy (MRS) estimates metabolite concentrations within the brain, but approaches and findings have been heterogeneous. To assess differences in brain metabolites between patients with ADHD and healthy controls, we searched 12 databases screening for MRS studies. Studies were divided into 'children and adolescents' and 'adults' and meta-analyses were performed for each brain region with more than five studies. The quality of studies was assessed by the Newcastle-Ottawa Scale. Thirty-three studies met our eligibility criteria, including 874 patients with ADHD. Primary analyses revealed that the right medial frontal area of children with ADHD presented higher concentrations of a composite of glutamate and glutamine (p = 0.02, SMD = 0.53). Glutamate might be implicated in pruning and neurodegenerative processes as an excitotoxin, while glutamine excess might signal a glutamate depletion that could hinder neurotrophic activity. Both neuro metabolites could be implicated in the differential cortical thinning observed in patients with ADHD across all ages. Notably, more homogeneous designs and reporting guidelines are the key factors to determine how suitable MRS is for research and, perhaps, for clinical psychiatry. Results of this meta-analysis provided an overall map of the brain regions evaluated so far, addressed the role of glutamatergic metabolites in the pathophysiology of ADHD, and pointed to new perspectives for consistent use of the tool in the field.

Indexed as

Attention Deficit Disorder with HyperactivityAdolescentAdultChildGlutamic AcidGlutamineHumansMagnetic Resonance SpectroscopyPrefrontal CortexGlutamic AcidGlutamineADHDAttention deficit hyperactivity disorderMeta-analysisMRSSpectroscopySystematic review

Identifiers

PMID35322293
OpenAlexW4220745962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.